--- title: "Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket" type: "News" locale: "en" url: "https://longbridge.com/en/news/287617199.md" description: "JOYY Inc shares rose 12.1% to $61.00 in pre-market trading after reporting better-than-expected Q1 earnings of $1.11 per share and sales of $555.7 million. Other notable gainers include Biomx Inc (+97.3%) and Artelo Biosciences Inc (+74.8%). Conversely, Akari Therapeutics PLC saw a decline of 25.2% after a significant rise the previous day." datetime: "2026-05-26T10:00:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287617199.md) - [en](https://longbridge.com/en/news/287617199.md) - [zh-HK](https://longbridge.com/zh-HK/news/287617199.md) generator: "portal-rs" --- # Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket Shares of **JOYY Inc** (NASDAQ:JOYY) rose sharply in pre-market trading following better-than-expected first-quarter results. JOYY reported quarterly earnings of $1.11 per share which beat the analyst consensus estimate of $1.02 per share. The company reported quarterly sales of $555.700 million which beat the analyst consensus estimate of $543.333 million. JOYY shares jumped 12.1% to $61.00 in pre-market trading. Here are some other stocks moving in pre-market trading. ### Gainers - **Biomx Inc** (NYSE:PHGE) gained 97.3% to $1.61 in pre-market trading after rising over 10% on Friday. - **Artelo Biosciences Inc** (NASDAQ:ARTL) gained 74.8% to $2.08 in pre-market trading after falling over 10% on Friday. - **Qtrex Quantum Ltd** (NASDAQ:QTEX) gained 52.4% to $1.11 in pre-market trading. - **Momentus Inc** (NASDAQ:MNTX) gained 34.4% to $9.92 in pre-market trading. - **Harmonic Inc** (NASDAQ:HLIT) rose 28.3% to $19.48 in pre-market trading after gaining around 20% on Friday. - **Work Medical Technology Group Ltd** (NASDAQ:WOK) rose 25% to $0.14  in pre-market trading after dipping 30% on Friday. - **CPS Technologies Corp** (NASDAQ:CPSH) jumped 24.7% to $7.48 in pre-market trading after surging 28% on Friday. - **Co-Diagnostics Inc** (NASDAQ:CODX) gained 22.7% to $6.22 in pre-market trading after jumping over 36% on Friday. - **Spectral AI Inc** (NASDAQ:MDAI) gained 22% to $3.27 in pre-market trading. ### Losers - **Akari Therapeutics PLC** (NASDAQ:AKTX) tumbled 25.2% to $13.66 in pre-market trading. Akari Therapeutics shares jumped 255% on Friday after the company released preclinical data showing AKTX‑101 produced synergistic activity alongside KRAS inhibition in KRAS-mutated pancreatic cancer models. - **rYojbaba Co Ltd** (NASDAQ:RYOJ) shares dipped 18.6% to $4.07 in pre-market trading after gaining 149% on Friday. - **DevvStream Corp** (NASDAQ:DEVS) declined 18.6% to $0.13 in pre-market trading after falling 5% on Friday. - **Akanda Corp** (NASDAQ:AKAN) fell 17% to $22.51 in pre-market trading after gaining over 15% on Friday. - **Aditxt Inc** (NASDAQ:ADTX) fell 16.3% to $0.43 in pre-market trading after dipping around 58% on Friday. - **Leifras Co Ltd** (NASDAQ:LFS) fell 15.6% to $2.99 in pre-market trading after jumping 89% on Friday. - **FBS Global Ltd** (NASDAQ:FBGL) fell 15.6% to $0.55 in pre-market trading after gaining 10% on Friday. - **Wheeler Real Estate Investment Trust Inc** (NASDAQ:WHLR) declined 12.3% to $1.00 in pre-market trading after falling around 11% on Friday. - **Teekay Corp Ltd** (NYSE:TK) fell 10% to $12.00 in pre-market trading. - **Eupraxia Pharmaceuticals Inc** (NASDAQ:EPRX) fell 7% to $6.61 in pre-market trading. *Photo via Shutterstock* ### Related Stocks - [JOYY.US](https://longbridge.com/en/quote/JOYY.US.md) - [ARTL.US](https://longbridge.com/en/quote/ARTL.US.md) - [PHGE.US](https://longbridge.com/en/quote/PHGE.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [QTEX.US](https://longbridge.com/en/quote/QTEX.US.md) - [MNTX.US](https://longbridge.com/en/quote/MNTX.US.md) - [HLIT.US](https://longbridge.com/en/quote/HLIT.US.md) - [WOK.US](https://longbridge.com/en/quote/WOK.US.md) - [CPSH.US](https://longbridge.com/en/quote/CPSH.US.md) - [CODX.US](https://longbridge.com/en/quote/CODX.US.md) - [MDAI.US](https://longbridge.com/en/quote/MDAI.US.md) - [AKTX.US](https://longbridge.com/en/quote/AKTX.US.md) - [RYOJ.US](https://longbridge.com/en/quote/RYOJ.US.md) - [DEVS.US](https://longbridge.com/en/quote/DEVS.US.md) - [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md) - [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md) - [LFS.US](https://longbridge.com/en/quote/LFS.US.md) - [FBGL.US](https://longbridge.com/en/quote/FBGL.US.md) - [WHLR.US](https://longbridge.com/en/quote/WHLR.US.md) - [TK.US](https://longbridge.com/en/quote/TK.US.md) - [EPRX.US](https://longbridge.com/en/quote/EPRX.US.md) - [YY.US](https://longbridge.com/en/quote/YY.US.md) - [MDAIW.US](https://longbridge.com/en/quote/MDAIW.US.md) - [DEVSF.US](https://longbridge.com/en/quote/DEVSF.US.md) - [WHLRP.US](https://longbridge.com/en/quote/WHLRP.US.md) - [WHLRL.US](https://longbridge.com/en/quote/WHLRL.US.md) - [WHLRD.US](https://longbridge.com/en/quote/WHLRD.US.md) ## Related News & Research - [JOYY beats top-line and bottom-line estimates; gives FY 2026 outlook](https://longbridge.com/en/news/296985959.md) - [JOYY Q2 2026 Earnings Preview](https://longbridge.com/en/news/296831874.md) - [BiomX: Zorronet Launches No-Code Control Over AI-Powered Autonomous Response Workflows | PHGE Stock News](https://longbridge.com/en/news/298045865.md) - [BiomX subsidiary Zorronet launches no-code builder for autonomous security workflows](https://longbridge.com/en/news/298045284.md) - [09:28 ETNew LabCentral Program "The Loop" Offers International Biotech Start-Ups and Partner Organizations Curated Learnings Directly from U.S. Market](https://longbridge.com/en/news/298328140.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**